Αποτελέσματα Αναζήτησης
1 Μαΐ 2018 · Most clinical trials cover the cost of the experimental medication and some help to cover travel costs as well as scans when needed. If you cannot afford a standard treatment, a clinical trial may be a way to receive treatment while minimizing out-of-pocket costs.
Cost: ~ $530 per cycle "How this cost is calculated" The cost displayed on the protocol is intended as rudimentary guide only for the Australian context. The cost includes anti-cancer drugs only (not antiemetics, supportive medications or consumables), unless otherwise indicated.
7 Δεκ 2022 · Selection and administration of adjuvant chemotherapy for HER2-negative breast cancer; Society guideline links: Breast cancer; Systemic treatment for HER2-positive metastatic breast cancer
14 Δεκ 2023 · Women with early-stage breast cancer that meet criteria for HER2 positivity are treated with chemotherapy and trastuzumab as adjuvant treatment. This topic review will cover the use of adjuvant HER2-directed therapy plus chemotherapy in patients with HER2-positive, early-stage breast cancer (stage I to III).
19 Ιουν 2024 · With a primary endpoint of 5-year iDFS, the investigators were able to demonstrate considerable improvements to iDFS for those on a trastuzumab-containing regimen (AC-TH or TCH).
31 Ιουλ 2017 · An analysis of the SEER-Medicare database shows that outcomes and healthcare costs for the two chemotherapy regimens are similar, with one difference.
25 Μαΐ 2020 · Abstract. Background: The optimal neoadjuvant treatment for HER2-positive breast cancer is unknown. We wanted to compare the efficacy and safety of the anthracycline regimen EC-TH versus nonanthracycline regimen TCH in neoadjuvant setting for HER2-positive breast cancer.
